Aurelius Health Group Tirzepatide Review: Microdosing, a Real Labeling Error & Honest Verdict (2026)

Aurelius Health Group is built entirely around compounded tirzepatide microdosing — a low-dose dual GIP/GLP-1 protocol rather than standard full-dose therapy — at a transparent $199/month after an $89 first month. This review independently confirmed a real dosing error on the company's own comparison table: it labels 2.4mg/week as tirzepatide's "Standard Full Dose," but 2.4mg is specifically semaglutide's maintenance dose — tirzepatide's own FDA label range is 2.5-15mg/week, with no 2.4mg dose at all. Every fact here comes from the company's own published program.

What Aurelius Health Group is

Aurelius Health Group is a telehealth platform, built specifically around compounded tirzepatide microdosing — this is a 1mg microdose program and nothing else; no labeled therapeutic dose is sold here, so it isn't an alternative to a full-dose prescription. It's LegitScript Certified, with a care-inclusive model bundling consults, monthly monitoring, and secure messaging.

A real, independently confirmed dosing-label error

This review directly examined Aurelius Health Group's own comparison table and found a genuine labeling error: a row labeled "Standard Full Dose" lists "2.4 mg / wk · Injectable." That figure is wrong for tirzepatide — 2.4mg/week is specifically semaglutide's (Wegovy's) maintenance dose; tirzepatide's own FDA label range runs 2.5mg to 15mg weekly, and no 2.4mg dose exists for it at all. This is a checkable factual error on the company's own site, not a matter of interpretation, and it's the kind of mistake worth knowing about on a company whose entire product is precise, low-dose titration.

What Aurelius Health Group costs

Pricing is fully published and bundled: $89 for the first month, then $199/month all-in thereafter. That's genuinely more transparent than most compounded competitors, though worth reading the $89 correctly — it's a first-month new-patient rate, not the ongoing price.

The brand-vs-compounded question

Aurelius Health Group dispenses compounded tirzepatide only, at microdose levels. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials — and the microdose protocol itself sits outside the labeled dosing range those trials tested. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Aurelius Health Group's real strengths: fully published, bundled pricing, LegitScript certification, a care-inclusive model rather than prescription-only, and unusual candor about the limited evidence base for microdosing elsewhere on the site. The trade-offs: this review's own direct check found a real dosing-label error on the site's comparison table; the $89 first-month rate isn't the ongoing price; no specific state count is published, only "most US states"; and — the core structural point — this is microdosing only, not a route to a standard therapeutic dose. As with any GLP-1 program, understand exactly what dose you're purchasing given the labeling confusion this review found; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Aurelius Health Group's pricing transparency and LegitScript certification are real positives, but this review independently confirmed a factual dosing error on its own comparison table — worth knowing before trusting the rest of its dosing information. If you want a full-dose therapeutic option rather than microdosing only, compare it against CoreAge Rx or bmiMD. See our best tirzepatide providers ranking for the full field.